Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites

Genome Medicine

Volumn 6, Issue 6, 2014, Pages

  Firouzi, Sanaz ^a   López, Yosvany ^a   Suzuki, Yutaka ^a   Nakai, Kenta ^a   Sugano, Sumio ^a   Yamochi, Tadanori ^a   Watanabe, Toshiki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GENOMIC DNA; DNA;

ARTICLE; CLONAL VARIATION; CLONE; COMPUTER MODEL; CONTROLLED STUDY; DNA BARCODING; DNA TEMPLATE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROVIRUS; VALIDATION PROCESS; HUMAN T-LYMPHOTROPIC VIRUS 1; METHODOLOGY; NEXT GENERATION SEQUENCING; VIRUS DNA CELL DNA INTERACTION;

EID: 84902914644     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm568     Document Type: Article

References (68)

1. Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005, 2:16.
2. Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2005, 2:17.
3. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K, Miwa M, Shimotohno K. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 1989, 80:191-195.
4. Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia. Front Microbiol 2012, 3:334.
5. Matsuoka M, Jeang K-T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007, 7:270-280.
6. Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 2002, 76:240-245.
7. Bangham CRM. HTLV-1. eLS 2011, Chichester, UK: John Wiley & Sons, Ltd, John W, Sons L.
8. Tsukasaki K, Tobinai K. Biology and treatment of HTLV-1 associated T-cell lymphomas. Best Pract Res Clin Haematol 2013, 26:3-14.
9. Nakano K, Watanabe T. HTLV-1 Rex: the courier of viral messages making use of the host vehicle. Front Microbiol 2012, 3:330.
10. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 2010, 116:1211-1219.
11. Iwanaga M, Watanabe T, Yamaguchi K. Adult T-Cell Leukemia: A Review of Epidemiological Evidence. Front Microbiol 2012, 3:322.
12. Taylor GP, Tosswill JH, Matutes E, Daenke S, Hall S, Bain BJ, Davis R, Thomas D, Rossor M, Bangham CR, Weber JN. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999, 22:92-100.
13. Yamaguchi K, Uozumi K, Taguchi H, Kikuch H, Okayama A, Kamihira S, Hino S, Nosaka K, Watanabe T. Nationwide Cohort Study of HTLV-1 Carriers in Japan: Joint Study on Predisposing Factors of ATL Development (JSPFAD). AIDS Res Hum Retroviruses 2007, 23:581-600.
14. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005, 24:6047-6057.
15. Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Ideda S, Katamine S, Yamada Y, Kamihira S, Tomonaga M. Integration Patterns of HTLV-I Provirus in Relation to the Clinical Course of ATL: Frequent Clonal Change at Crisis From Indolent Disease. Blood 1997, 89:948-956.
16. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 1984, 81:2534-2537.
17. Cavrois M, Gessain A, Wain-Hobson S, Wattel E. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 1996, 12:2419-2423.
18. Etoh K, Tamiya S, Yamaguchi K, Okayama A, Tsubouchi H, Ideta T, Mueller N, Takatsuki K, Matsuoka M. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 1997, 57:4862-4867.
19. Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G-I, Kubuki Y, Mueller N, Hsieh C-C, Tachibana N, Tsubouchi H. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004, 110:621-625.
20. G-i T, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, Hsieh C-C, Tsubouchi H. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis 2005, 191:1140-1147.
21. Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol 2007, 81:6731-6741.
22. Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, Berry C, Bushman FD, Taylor GP, Bangham CRM. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011, 117:3113-3122.
23. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CRM. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 2012, 120:3488-3490.
24. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CRM. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog 2013, 9:e1003271.
25. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995, 69:2863-2868.
26. Gabet AS, Mortreux F, Talarmin A, Plumelle Y, Leclercq I, Leroy A, Gessain A, Clity E, Joubert M, Wattel E. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000, 19:4954-4960.
27. Kamihira S, Iwanaga M, Doi Y, Sasaki D, Mori S, Tsurda K, Nagai K, Uno N, Hasegawa H, Yanagihara K, Morinaga Y, Tsukasaki K, Taniguchi H. Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL. Int J Hematol 2012, 95:399-408.
28. Satoh M, Toma H, Sugahara K, Etoh K, Shiroma Y, Kiyuna S, Takara M, Matsuoka M, Yamaguchi K, Nakada K, Fujita K, Kojima S, Hori E, Tanaka Y, Kamihira S, Sato Y, Watanabe T. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S-stercoralis. Oncogene 2002, 21:2466-2475.
29. Ikeda S, Momita S, Kinoshita K-I, Kamihira S, Moriuchi Y, Tsukasaki K, Ito M, Kanda T, Moriuchi R, Nakamura T. Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low-and high-risk population. Blood 1993, 82:2017-2024.
30. Yamaguchi K, Seiki M, Yoshida M, Nishimura H, Kawano F, Takatsuki K. The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood 1984, 63:1235-1240.
31. Takemoto S, Matsuoka M, Yamaguchi K, Takatsuki K. A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 1994, 84:3080-3085.
32. Imaizumi Y, Iwanaga M, Tsukasaki K, Hata T, Tomonaga M, Ikeda S. Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes (" pre-ATL" ) in a 20-year follow-up study. Blood 2005, 105:903-904.
33. Wongstaal F, Hahn B, Manzari V, Colombini S, Franchini G, Gelmann EP, Gallo RC. A survey of human leukemias for sequences of a human retrovirus. Nature 1983, 302:626-628.
34. Cavrois M, Wain-Hobson S, Wattel E. Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol 1995, 146:179-184.
35. Ohshima K, Mukai Y, Shiraki H, Suzumiya J, Tashiro K, Kikuchi M. Clonal integration and expression of human T-cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR. Am J Hematol 1997, 54:306-312.
36. Nowell PC. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
37. Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012, 481:306-313.
38. Sprouffske K, Merlo Lauren MF, Gerrish Philip J, Maley Carlo C, Sniegowski Paul D. Cancer in Light of Experimental Evolution. Curr Biol 2012, 22:R762-R771.
39. Melo FDSE, Vermeulen L, Fessler E, Medema JP. Cancer heterogeneity-a multifaceted view. EMBO Rep 2013, 14:686-695.
40. Aird D, Ross MG, Chen W-S, Danielsson M, Fennell T, Russ C, Jaffe DB, Nusbaum C, Gnirke A. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol 2011, 12:R18.
41. Acinas SG, Sarma-Rupavtarm R, Klepac-Ceraj V, Polz MF. PCR-induced sequence artifacts and bias: insights from comparison of two 16S rRNA clone libraries constructed from the same sample. Appl Environ Microbiol 2005, 71:8966-8969.
42. Polz MF, Cavanaugh CM. Bias in template-to-product ratios in multitemplate PCR. Appl Environ Microbiol 1998, 64:3724-3730.
43. Suzuki MT, Giovannoni SJ. Bias caused by template annealing in the amplification of mixtures of 16S rRNA genes by PCR. Appl Environ Microbiol 1996, 62:625-630.
44. Dabney J, Meyer M. Length and GC-biases during sequencing library amplification: A comparison of various polymerase-buffer systems with ancient and modern DNA sequencing libraries. Biotechniques 2012, 52:87.
45. Raabe CA, Tang TH, Brosius J, Rozhdestvensky TS. Biases in small RNA deep sequencing data. Nucleic Acids Res 2014, 42:1414-1426.
46. Berry CC, Gillet NA, Melamed A, Gormley N, Bangham CRM, Bushman FD. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics 2012, 28:755-762.
47. Gini C. Sulla misura della concentrazione e della variabilita dei caratteri. Transactions of the Real Istituto Veneto di Scienze 1914, LIII:1203.
48. Gini C. Concentration and dependency ratios (in Italian). English Translation in Rivista di Politica Economica 1997, 87:769-789.
49. Biomaterial resource bank of HTLV-1 carriers, Joint Study on Predisposing Factors of ATL Development (JSPFAD) [http://htlv1.org/old/bank-en.html].
50. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991, 79:428-437.
51. Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer 1984, 34:221-228.
52. Devon RS, Porteous DJ, Brookes AJ. Splinkerettes-improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res 1995, 23:1644-1645.
53. Uren AG, Mikkers H, Kool J, van der Weyden L, Lund AH, Wilson CH, Rance R, Jonkers J, van Lohuizen M, Berns A, Adams DJ. A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat Protoc 2009, 4:789-798.
54. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci 1983, 80:3618-3622.
55. Human Genome Center (HGC), the institute of medical Science, the University of Tokyo [http://www.hgc.jp/].
56. FastQC: A quality control tool for high throughput sequence data. [http://www.bioinformatics.babraham.ac.uk/projects/fastqc/].
57. UCSC Genome Browser [http://genome.ucsc.edu].
58. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25.
59. Stasinopoulos DM, Rigby RA. Generalized additive models for location scale and shape (GAMLSS) in R. J Stat Softw 2007, 23:1-46.
60. StatsDirect Medical Statistics Software [http://www.statsdirect.com/].
61. Chatburn RL. Evaluation of instrument error and method agreement. AANA J 1996, 64:261-268.
62. Dohm JC, Lottaz C, Borodina T, Himmelbauer H. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing. Nucleic Acids Res 2008, 36:e105.
63. Hillier LW, Marth GT, Quinlan AR, Dooling D, Fewell G, Barnett D, Fox P, Glasscock JI, Hickenbotham M, Huang W, Magrini VJ, Richt RJ, Sander SN, Stewart DA, Stromberg M, Tsung EF, Wylie T, Schedl T, Wilson RK, Mardis ER. Whole-genome sequencing and variant discovery in C. elegans. Nat Methods 2008, 5:183-188.
64. Quail MA, Kozarewa I, Smith F, Scally A, Stephens PJ, Durbin R, Swerdlow H, Turner DJ. A large genome centre's improvements to the Illumina sequencing system. Nat Methods 2008, 5:1005-1010.
65. Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 2008, 18:1851-1858.
66. Nakamura K, Oshima T, Morimoto T, Ikeda S, Yoshikawa H, Shiwa Y, Ishikawa S, Linak MC, Hirai A, Takahashi H, Altaf-Ul-Amin M, Ogasawara N, Kanaya S. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res 2011, 39:e90-e90.
67. Minoche AE, Dohm JC, Himmelbauer H. Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and Genome Analyzer systems. Genome Biol 2011, 12:R112.
68. Kivioja T, Vähärautio A, Karlsson K, Bonke M, Enge M, Linnarsson S, Taipale J. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods 2012, 9:72-74.